Document Detail


Emergency contraception: update and review.
MedLine Citation:
PMID:  20352558     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Emergency contraception (EC) is the postcoital method of pregnancy prevention. Three methods of EC are used in the United States: (1) levonorgestrel-only pills, Plan B (Barr Pharmaceuticals, LLC, New Jersey) (2) combined estrogen and progestin pills, and (3) the copper intrauterine device. Used within 120 hours after unprotected sexual intercourse, EC reduces the risk of pregnancy by 60 to 94%. EC is a critical component of medical care for sexual assault survivors, and several states have laws mandating this standard of care. Levonorgestrel-only EC is available to women >or=17 years of age without a prescription. Women who were counseled by their clinician about EC were 11 times more likely to use EC in the following 12 months. Advance provision of EC to women has not been found to decrease rates of unintended pregnancy compared with routine pharmacy access; however, women routinely prefer advance provision. The newly approved by the Food and Drug Administration single-dose EC, Plan B One-Step (Barr Pharmaceuticals, LLC), may affect unintended pregnancy rates among EC users by simplifying use.
Authors:
Aileen Langston
Related Documents :
2015938 - Pregnancy avoidance and coital behavior.
17046378 - Comparison of efficacy and complications of iud insertion in immediate postplacental/ea...
16772888 - Novel pachometry calibration.
9180818 - Norplant in south africa--the first 100 patients.
16126718 - Risk of complications during pregnancy after senning or mustard (atrial) repair of comp...
9510058 - Effects of increasing gestation, cortisol and maternal undernutrition on hypothalamic n...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-03-29
Journal Detail:
Title:  Seminars in reproductive medicine     Volume:  28     ISSN:  1526-4564     ISO Abbreviation:  Semin. Reprod. Med.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-06-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100909394     Medline TA:  Semin Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  95-102     Citation Subset:  IM    
Copyright Information:
Thieme Medical Publishers.
Affiliation:
Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York 10032, USA. al2632@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contraception, Postcoital / adverse effects,  methods*,  trends
Contraceptive Agents, Female / administration & dosage,  adverse effects,  therapeutic use
Contraceptives, Oral, Combined / administration & dosage,  adverse effects,  therapeutic use
Ethinyl Estradiol / administration & dosage,  adverse effects,  therapeutic use
Female
Humans
Intrauterine Devices, Copper / adverse effects
Levonorgestrel / administration & dosage,  adverse effects,  therapeutic use
Norpregnadienes / administration & dosage,  therapeutic use
Patient Education as Topic
Pregnancy
United States
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Contraceptives, Oral, Combined; 0/Norpregnadienes; 0/ulipristal; 57-63-6/Ethinyl Estradiol; 797-63-7/Levonorgestrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cognitive and emotional factors associated with elective breast augmentation among young women.
Next Document:  Transcervical Sterilization.